South Wales, Sept. 18 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "StemcellX" on Sept. 2. The details about the trademark application no. UK00004439681 published in the journal no. 2026/038 (Sept. 18).
Stem CellX limited filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral diseases; Dermatological pharmaceutical products; Pharmaceutical products for the treatment of infectious diseases; Pharmaceuticals; Injectable pharmaceuticals; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical products for treating respiratory diseases; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical drugs; Pharmaceutical products for skin care for animals; Cardiovascular pharmaceuticals; Pharmaceutical products for ophthalmological use; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Dermatological pharmaceutical substances; Pharmaceutical preparations for the treatment of tumours; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for the treatment of kidney disorders; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for the treatment of osteoporosis; Therapeutic creams [medical]; Pharmaceutical preparations for the treatment of diseases of the metabolic system; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of Musculo-skeletal disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Ocular pharmaceuticals; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of digestive diseases; Pharmaceutical creams; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for the treatment of diseases of the musculo-skeletal system; Pharmaceutical skin lotions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cardiovascular disease; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for use in dermatology; Lotions for pharmaceutical purposes; Pharmaceutical implants.
Class 41 : Education; Health education; Education and training; Adult education services; Further education; Education services relating to health; Adult education services relating to medicine; Education services relating to medicine.
Class 42 : Pharmaceutical products development; Pharmaceutical drug development services; Testing of pharmaceuticals; Research of pharmaceuticals; Development of pharmaceutical preparations and medicines; Conducting clinical trials for pharmaceutical products; Pharmaceutical research services; Information technology services for the pharmaceutical and healthcare industries; Research and development of vaccines and medicines.
Class 44 : Regenerative medicine services; Medical treatment using cultured cells; Analysis of human tissues for medical treatment; Therapeutic treatment of the body; Stem cell therapy services; Medical services relating to the removal, treatment and processing of stem cells.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004439681
Disclaimer: Curated by HT Syndication.
